[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Mooning Stock to Own for Decades and 2 That Underwhelm

1 Mooning Stock to Own for Decades and 2 That Underwhelm

COLL : 37.03 (+3.23%)
TREX : 48.47 (-0.45%)
ALHC : 23.80 (-0.87%)
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

ULTA : 461.33 (+1.44%)
COLL : 37.03 (+3.23%)
HAPN : 19.69 (-4.14%)
3 of Wall Street’s Favorite Stocks We Approach with Caution

3 of Wall Street’s Favorite Stocks We Approach with Caution

COLL : 37.03 (+3.23%)
SUPN : 48.05 (+1.35%)
REAX : 2.17 (+9.60%)
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan...

COLL : 37.03 (+3.23%)
2 Reasons to Sell COLL and 1 Stock to Buy Instead

2 Reasons to Sell COLL and 1 Stock to Buy Instead

COLL : 37.03 (+3.23%)
Collegium to Participate in 2026 Jefferies Global Healthcare Conference

STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global...

COLL : 37.03 (+3.23%)
3 Growth Stocks We’re Skeptical Of

3 Growth Stocks We’re Skeptical Of

GH : 167.98 (-1.63%)
COLL : 37.03 (+3.23%)
GATX : 173.67 (+1.13%)
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

COLL : 37.03 (+3.23%)
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 37.03 (+3.23%)
TMO : 523.44 (+1.97%)
XRAY : 11.65 (+5.05%)
HALO : 79.45 (+3.17%)
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS...

COLL : 37.03 (+3.23%)

Barchart Exclusives

FedEx Is Abandoning Its Supply Chain Business. FDX Stock Investors Need the Logistics Giant to Protect Its Core Network.
FedEx is selling FedEx Supply Chain to shipping giant CMA CGM for $1.4 billion, narrowing its focus to premium B2B shipping, logistics, and freight moves. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.